Aviptadil

Synthetic vasoactive intestinal peptide (VIP) analog API with multi-target therapeutic potential. Potent VIP receptor activation delivering lung protection, vasodilation, anti-inflammation, and immunomodulation.

Aviptadil, also known as RLF-100 or ZYESAMI, is a synthetic form of Vasoactive Intestinal Peptide (VIP), a 28-amino acid linear polypeptide that acts as a neurotransmitter in the central and enteric nervous systems. Aviptadil is structurally identical to human VIP and exerts potent vasodilatory, anti-inflammatory, and cytoprotective effects by binding to VPAC1 and VPAC2 receptors distributed throughout the body.

CAS 40077-57-4
Molecular Formula C₁₄₇H₂₃₈N₄₄O₄₂S
Molecular Weight 3325.80 g/mol
Category Cardiovascular & Coagulation Peptides
Purity >=99% (HPLC)
Status GMP-compliant, FDA-ready
Applications Acute respiratory distress syndrome, pulmonary hypertension, severe lung infection, erectile dysfunction

 

CAS

40077-57-4

Applications

, , , ,

Leave a message